Comparison

VTP50469 European Partner

Item no. TMO-T13336-200mg
Manufacturer TargetMol
CASRN 2169916-18-9
Amount 200 mg
Quantity options 100 mg 10 mg 1 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 0,9892
Smiles CC(C)N(C(C)C)C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(C)(=O)=O)CC2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Apoptosis, Epigenetic Reader Domain, Histone Methyltransferase
Shipping condition Cool pack
Available
Manufacturer - Targets
Histone Methyltransferase|||Epigenetic Reader Domain|||Apoptosis
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
630, 82
Description
VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.
Pathways
Apoptosis|||Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close